Pasar al contenido principal

POTENCIAL TRASLACIONAL DE INHIBIDORES DEL FACTOR DE TRANSCRIPCION HSF1 COMO DROGAS ANTICANCERIGENAS

PID2021-126325OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIV. LA PAZ

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Tracking encephalitogenic cell fate during induction of adoptive transfer experimental autoimmune encephalomyelitis using dually detectable nanoparticles

  • García Hernández, Ruth
  • Nakal-Chidiac, Alberto
  • Palao-Suay, Raquel
  • Martín-Saldaña, Sergio
  • Hernández, Rebeca
  • Criado-González, Miryam
  • García-Grande, Aránzazu
  • Coronado, María José
  • Zamora Cañadas, Carmen
  • Martín-Saavedra, Francisco
  • Escudero-Duch, Clara
  • Sánchez-Casanova, Silvia
  • Vilaboa, Nuria
  • Salinas, Beatriz
  • García-Fernández, Luis
  • Sánchez-López, Antonio J.
  • Aguilar de Armas, María Rosa
**Experimental procedures are fully described in the associated publication (DOI pending).** **Main techniques include:** * Nuclear Magnetic Resonance (NMR) * Thermogravimetric Analysis (TGA) * Cryo-Transmission Electron Microscopy (Cryo-TEM) * Confocal fluorescence microscopy * Flow cytometry * Magnetic Resonance Imaging (MRI) * Thermography * Dynamic Light Scattering (DLS) and Zeta Potential * In vivo EAE scoring, All processing, normalization, and analytical pipelines are described at DOI. Raw data is provided without manipulation except for standard export procedures.**, This dataset contains the complete set of raw experimental data generated for the study on dually detectable nanoparticles used to track encephalitogenic cell fate during induction of adoptive transfer Experimental Autoimmune Encephalomyelitis. It includes physicochemical characterization of nanoparticles, microscopy images, thermographic and MRI-related data, cytometry measurements, in vivo disease scoring, and viability assays. These data enable full reproducibility of the analyses presented in the related publication and allow reuse for nanoparticle tracking, immunological responses, and biomaterials research., This work was supported by the Spanish Ministry of Science, Innovation and Universities: grants PID2023-149301OB-I00 and PID2021-126325OB-I00 funded by MICIU/AEI (DOI: 10.13039/501100011033) and by ERDF/EU and by Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III. (Refs. CB06/01/0013 and CB06/01/0008). This research work was performed in the framework of the Nanomedicine CSIC HUB (Ref. 202180E048)., 00 - Nuclear Magnetic Resonance 01 - Thermogravimetric analysis 02 - Cryogenic Transmission Electron Microscopy images 03 - MRI (FALTA) 04 - Confocal Imaging 05 - Flow Cytometry data 06 - Alamar Blue data 07 - In vivo data analysis 08 - Thermogram images 09 - Dynamic Light Scattering and Zeta Potential data, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An All-in-One Photothermal Nanocomposite Hydrogel for Controlling Inducible Transgene Expression

  • Serrano-Yamba, Rodrigo
  • Escudero-Duch, Clara
  • Yus, Cristina
  • Recuero, María
  • López García, Daniel
  • Saldaña, Laura
  • Arruebo, Manuel
  • Vilaboa, Nuria
We have developed a remotely near-infrared (NIR)-activated, implantable fibrin hydrogel for the controlled induction of transgene expression, designed to decouple the therapeutic efficacy of rapamycin from its systemic toxicity. Rapamycin, a drug widely used in clinical practice as an immunosuppressant and antiproliferative agent, is a potent transcriptional inducer that enables tightly regulated temporal transgene expression through chemically induced dimerization. However, its utility as a dimerizer is hindered by the unintended systemic immunosuppression and off-target effects inherent to its conventional administration. To address this, we developed poly(lactic-co-glycolic acid) (PLGA) nanoparticles to encapsulate rapamycin, aiming to facilitate localized delivery and enhance drug stability. Engineered cells harboring a dual heat- and dimerizer-responsive gene switch exhibited robust reporter transgene expression following nanoparticle treatment and thermal activation. Nanoencapsulation preserved rapamycin activity against thermal and hydrolytic degradation, enabling superior, long-term dimerizer function compared to the free drug. To create a remotely actuated platform, we developed photothermal hydrogels by incorporating hollow gold nanoparticles and rapamycin-loaded PLGA nanoparticles within a fibrin matrix hosting the reporter cells. In mice, NIR irradiation of subcutaneously implanted constructs achieved transgene induction levels comparable to systemic administration of rapamycin. Notably, nanoparticle-mediated delivery resulted in negligible circulating rapamycin concentrations. Furthermore, localized rapamycin release initially promoted a pro-healing M2 macrophage phenotype, followed by a late-stage transition toward an M1-dominant profile that likely facilitated the clearance of scaffold degradation products. In hydrogels incorporating cells harboring a gene switch to control human VEGF165 production, NIR irradiation triggered a robust angiogenic cascade characterized by transient erythema followed by an increase in CD31+ microvascular density. Collectively, these data demonstrate the potential of this light-triggered and rapamycin-dependent platform as a customizable and safe tool for achieving the control required to advance the next-generation of site-specific, transgenic protein therapies., This work was funded by MCIN/AEI/10.13039/ 501100011033 and by “ERDF A way of making Europe”, grant numbers PID2021-126325OB-I00 (to N.V.), PID2023-146091OB-I00 (to M.A.), CEX2023-001286-S (to M.A.), by grants PI22/00939 and PI25/01326 from the Instituto de Salud Carlos III (ISCIII) and cofunded by the European Union (to L.S.), and by the Autonomous Community of Madrid, Spain, grant P2022/BMD-7406 (to N.V.), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

DATASET from Tracking encephalitogenic cell fate during induction of adoptive transfer experimental autoimmune encephalomyelitis using dually detectable nanoparticles

  • García Hernández, Ruth
  • Nakal-Chidiac, Alberto
  • Palao-Suay, Raquel
  • Martín-Saldaña, Sergio
  • Hernández, Rebeca
  • Criado-González, Miryam
  • García-Grande, Aránzazu
  • Coronado, María José
  • Zamora Cañadas, Carmen
  • Martín-Saavedra, Francisco
  • Escudero-Duch, Clara
  • Sánchez-Casanova, Silvia
  • Vilaboa, Nuria
  • Salinas, Beatriz
  • García-Fernández, Luis
  • Sánchez-López, Antonio J.
  • Aguilar de Armas, María Rosa
[Methods for processing the data] **All processing, normalization, and analytical pipelines are described at DOI. Raw data is provided without manipulation except for standard export procedures.** [Description of methods used for the collection/generation of data] **Experimental procedures are fully described in the associated publication (DOI pending).** **Main techniques include:** * Nuclear Magnetic Resonance (NMR) * Thermogravimetric Analysis (TGA) * Cryo-Transmission Electron Microscopy (Cryo-TEM) * Confocal fluorescence microscopy * Flow cytometry * Magnetic Resonance Imaging (MRI) * Thermography * Dynamic Light Scattering (DLS) and Zeta Potential * In vivo EAE scoring, **1. File List:** 00 - Nuclear Magnetic Resonance FID data from 1H-NMR of chitosan, palmitic acid and chitosan-palmitic acid 01 - Thermogravimetric analysis Data in XLS format of chitosan and chitosan-palmitic acid 02 - Cryogenic Transmission Electron Microscopy images JPG images of ChPA-IR820\_FF\_1.10, ChPA-IR820\_FF\_1.100 and ChPA-IR820\_FF\_1.1000 03 - MRI In\_vivo: .dcm (DICOM) T2 images contrast of the intraperitoneal injection of T4-labeled cells In\_vitro: .dcm (DICOM) T2 images contrast of Ch/PA-IR820/AA-FF nanoparticles 04 - Confocal Imaging TIF images of the different organs (Brain, heart, Kidney, Lung, Lymph Nodes, Spinal Cord, Spleen) and blood with various treatments at different times. \_z0: Merged image \_z0\_ch00: Reflexion channel \_z0\_ch01: IR channel \_z0\_ch02: Brightfield channel \_z0\_ch03: Green channel 05 - Flow Cytometry data .mqd dataset of flow cytometry for different treatments (T1, T2, T3, T4, and T5) at different times. 06 - Alamar Blue data XLS data from Alamar blue 07 - In vivo data analysis XLS data from disease scoring 08 - Thermogram images .bmt datasets from thermographic pictures of the different systems (Water, DMEM, Ch/PA-IR820, Ch/PA-IR820/A-FF, Ch/PA, A-FF) 09 - Dynamic Light Scattering and Zeta Potential data .dts datasets from the different nanoparticles, This dataset contains the complete set of raw experimental data generated for the study on dually detectable nanoparticles used to track encephalitogenic cell fate during induction of adoptive transfer Experimental Autoimmune Encephalomyelitis. It includes physicochemical characterization of nanoparticles, microscopy images, thermographic and MRI-related data, cytometry measurements, in vivo disease scoring, and viability assays. These data enable full reproducibility of the analyses presented in the related publication and allow reuse for nanoparticle tracking, immunological responses, and biomaterials research., Spanish Ministry of Science, Innovation, and Universities: grants PID2023-149301OB-I00 and PID2021-126325OB-I00 funded by MICIU/AEI (DOI: 10.13039/501100011033) and by ERDF/EU Instituto de Salud Carlos III (ISCIII): Project PT23/00027, co-funded by the European Union; Comunidad de Madrid: Projects S2022/BMD-7406 (RADIOPROTECT-CM) and S2022/BMD-7403 (RENIM-CM); Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III. (Refs. CB06/01/0013 and CB06/01/0008). LC and BS are supported by the Ministerio de Ciencia e Innovación through the Ramon y Cajal Program (RYC2023-043775-I and RYC2023-043741-I). This research was performed within the framework of the Nanomedicine CSIC HUB (Ref. 202180E048)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

An All-in-One Photothermal Nanocomposite Hydrogel for Controlling Inducible Transgene Expression

  • Serrano-Yamba, Rodrigo
  • Escudero-Duch, Clara
  • Yus, Cristina
  • Recuero, María
  • Lopez, Daniel
  • Saldaña, Laura
  • Arruebo, Manuel
  • Vilaboa, Nuria
We have developed a remotely near-infrared (NIR)-activated, implantable fibrin hydrogel for the controlled induction of transgene expression, designed to decouple the therapeutic efficacy of rapamycin from its systemic toxicity. Rapamycin, a drug widely used in clinical practice as an immunosuppressant and antiproliferative agent, is a potent transcriptional inducer that enables tightly regulated temporal transgene expression through chemically induced dimerization. However, its utility as a dimerizer is hindered by the unintended systemic immunosuppression and off-target effects inherent to its conventional administration. To address this, we developed poly(lactic-co-glycolic acid) (PLGA) nanoparticles to encapsulate rapamycin, aiming to facilitate localized delivery and enhance drug stability. Engineered cells harboring a dual heat- and dimerizer-responsive gene switch exhibited robust reporter transgene expression following nanoparticle treatment and thermal activation. Nanoencapsulation preserved rapamycin activity against thermal and hydrolytic degradation, enabling superior, long-term dimerizer function compared to the free drug. To create a remotely actuated platform, we developed photothermal hydrogels by incorporating hollow gold nanoparticles and rapamycin-loaded PLGA nanoparticles within a fibrin matrix hosting the reporter cells. In mice, NIR irradiation of subcutaneously implanted constructs achieved transgene induction levels comparable to systemic administration of rapamycin. Notably, nanoparticle-mediated delivery resulted in negligible circulating rapamycin concentrations. Furthermore, localized rapamycin release initially promoted a pro-healing M2 macrophage phenotype, followed by a late-stage transition toward an M1-dominant profile that likely facilitated the clearance of scaffold degradation products. In hydrogels incorporating cells harboring a gene switch to control human VEGF165 production, NIR irradiation triggered a robust angiogenic cascade characterized by transient erythema followed by an increase in CD31+ microvascular density. Collectively, these data demonstrate the potential of this light-triggered and rapamycin-dependent platform as a customizable and safe tool for achieving the control required to advance the next-generation of site-specific, transgenic protein therapies.